Application Type
Patent
Application SubType
PCT National Phase
(10) Registration Number and Date
BNN20200040 14.05.2020
Status
Published
(180) Expiration Date
(20) Filing Number and Date
BN N/2020/0040 15.11.2018
(40) Publication Number and Date
BN N/2020/0040
A
14.05.2020
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
US 62/587,604
17.11.2017
(51) IPC Classes
(72) Inventor
(EN) FAYADAT-DILMAN, Laurence
(EN) MEEHL, Michael, A.
(EN) BRANDISH, Philip, E.
(EN) JUAN, Veronica
(EN) MIECZKOWSKI, Carl
(EN) SINGH, Latika
(74) Representative Name
(EN) m/s Spruson & Ferguson Pte Ltd : C/O AIP Law Unit 404A-410A, 4th Floor, Wisma Jaya, Jalan Pemancha, Bandar Seri Begawan BS8811,
(54) Title
(EN) ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF
(57) Abstract
(EN)

Humanized, non-promiscuous monoclonal antibodies specific for immunoglobulin-like transcript 3 (ILT3), also known as Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4), are described.

(58) Citations
Document Type Date Action
Event NameDateStatus
Filing15.11.2018Filed
PCT National Phase Entry14.05.2020PCT National Phase
Registration14.05.2020Registered
Publication14.05.2020Published